Agfa HealthCare's DR Systems Take Top Spot in Three Categories in MD Buyline's "User Satisfaction Trending" Survey

Agfa HealthCareAgfa HealthCare announced today it has been ranked first in three categories of MD Buyline's Q2.2015 "User Satisfaction Trending" Survey for Radiographic Unit, Digital and Conventional. Taking the top spot in "System Reliability," "Service Response Time," and "Service Repair Quality," Agfa HealthCare's Direct Radiography (DR) systems were rated higher than the competition in these areas according to survey findings.

MD Buyline's industry experts survey hundreds of end users to gain customer experiences in order to develop quarterly "User Satisfaction Trending" reports. Based on user feedback, MD Buyline rates suppliers on a scale from 1 to 10 in six categories, with Agfa HealthCare leading in half of the categories for its DR products.

According to the report, Agfa HealthCare users "appreciate that they are able to continue utilizing MUSICA image processing as they've transitioned from Agfa HealthCare's CR (Computed Radiography) systems to DR." In addition, according to interview feedback, "Agfa HealthCare's DR system owners applauded the ease of transition from CR to DR with the continuity of the MUSICA workstation and user interface."

Agfa HealthCare has a full portfolio of DR systems, from telescoping mobile DR systems to high throughput C-arms, floor mounted and fully automated overhead DR systems to DR Retrofit solutions. Agfa HealthCare provides innovative, user friendly and configurable DR systems to meet the imaging requirements of large and small facilities.

All of Agfa HealthCare's DR solutions are powered by industry-leading MUSICA image processing and the convenience provided by its workstation with a single click user interface. Now in its third generation, MUSICAtechnology provides consistent, high-quality results and virtually eliminates the need for post processing adjustments by the technologist or radiologist. The high image quality provided by MUSICA image processing, when used with Cesium Iodide detector technology, has become the gold standard in DR Imaging and also provides up to 60% dose reduction* potential for patients using Agfa HealthCare DR systems.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world’s leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,865 million euro in 2013.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2013 were 1,160 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...